Allergan plc has released Viberzi (eluxadoline), a treatment for irritable bowel syndrome with diarrhea (IBS-D), to U.S. pharmacies. The company said Monday that Viberzi, a twice-daily oral medication, relieves the core symptoms of IBS-D: recurrent diarrhea and abdominal pain.
Valeant Pharmaceuticals International Inc. and Walgreens have entered agreements in which the drug maker will directly distribute branded prescription drugs in a range of therapeutical areas to the pharmacy chain at reduced pricing.
Endo International plc has received an extension of its exclusive U.S. marketing rights for Voltaren Gel (diclofenac sodium topical gel 1%), a nonsteriodal anti-inflammatory drug (NSAID). Endo said Monday that it also was granted extended U.S.
Newell Rubbermaid Inc. is buying Jarden Corp. for about $13.2 billion in cash and stock, combining brands including Paper Mate, Sunbeam and Yankee Candle. Jarden shareholders will receive, per share, $21 and 0.862 shares of Newell Rubbermaid stock at closing.
Horizon Pharma plc plans to acquire Crealta Holdings LLC for $510 million in cash. Horizon said the deal will bring the company Krystexxa (pegloticase), the first and only Food and Drug Administration-approved drug for chronic refractory gout.
It is said that patience is a virtue. With respect to medication therapy management (MTM) by chain pharmacists, patience has been more a necessity than a virtue. Among and between health care providers, including pharmacists, there have been MTM pilot projects and some test collaborations.
It’s not evident to anyone entering Rite Aid’s busy store at 50th Street and 8th Avenue in Manhattan that this location was totally remodeled in 10 days.
Takeda Pharmaceutical Co. has released Ninlaro capsules (ixazomib), a blood cancer medication, in the United States. Takeda said Friday that Ninlaro is the first and only oral proteasome inhibitor.
The Federal Trade Commission has requested additional information from Walgreens Boots Alliance (WBA) Inc. and Rite Aid Corp. regarding WBA’s proposed acquisition of Rite Aid.
Jelly Belly Candy Co. has a way for the Force to be with retailers. For the debut of the major motion picture “Star Wars: The Force Awakens” on Dec. 18, the candy maker next month plans to release two new products for its Star Wars Collection of gifts: the 8.5-oz. “Star Wars: The Force Awakens”
BENTONVILLE, Ark. – Stephen Quinn reportedly is retiring next month as Walmart’s chief marketing officer. The discounter intends to hire Michael Francis, who spent nearly 27 years at Target Corp., as a marketing consultant, according to an article Thursday by the Wall Street Journal.
With many seniors moving to new Medicare Part D coverage for next year, Publix Super Markets is urging them to switch their prescriptions to its pharmacies.
Despite the emergence of multiple mobile payment platforms, Walmart has gone ahead and launched its own: Walmart Pay.
The Global Market Development Center (GMDC) and Nielsen have refreshed their proprietary GMDC/Nielsen General Merchandise Hierarchy data set.
In tandem with a congressional hearing, the National Community Pharmacists Association called on lawmakers to take a closer look at recent generic drug price hikes and their impact on patients and community pharmacists.
Amneal Pharmaceuticals LLC has begun shipping lidocaine 5% ointment to lead off the launch of a new lidocaine product line. Amneal said late Tuesday that its lidocaine 5% ointment is available in a 35.44-g tube with child-resistant cap and in a 50-g jar.
